课题基金 / 基金详情

The Role of MAP Kinase in The Signal Transduction Pathways Activated by Mechanical Stress in Mesenchymal Cells.

The Role of MAP Kinase in The Signal Transduction Pathways Activated by Mechanical Stress in Mesenchymal Cells.
MAP 激酶在间充质细胞机械应力激活的信号转导途径中的作用。
批准号:
09672094
负责人:
MORIYAMA Keiji
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

MORIYAMA Keiji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Studies on interleukin-6 (IL-6) in bone metabolism in response to mechanical stress have been accumulating. However, its effects on osteoblasts are still unclear because the results are conflicting depending on the study models employed. We reasoned that these conflicting data are due to variable expression levels of membrane-bound IL-6 receptors (IL-6Rs). In the present study, we found that IL-6 in combination with soluble IL-6R (sIL-6R) consistently caused a marked elevation of alkaline phosphatase and a decrease in proliferation in the human osteoblastic cell line MG-63, which expressed no detectable membrane-bound IL-6R and failed to respond to IL-6. These effects of IL-6/sIL-6R were blocked by neutralizing antibodies to the IL-6 signal transducer gp 130, suggesting an involvement of IL-6 signaling in the elicitation of the effects of IL-6/sIL6R.Upon stimulation with IL-6/sIL-6R, the gp 130, cytoplasmic Janus kinases JAK1 and JAK2 were tyrosine phosphorylated. Moreover, signal transducers and activators of transcription STAT1 and STAT3 were also tyrosine phosphorylated, translocated to the nucleus, and bound to the putative STAT-binding DNA elements. In addition, mitogen-activated protein (MAP) kinase was also activated in response to IL-6/sIL-6R.These data demonstrate that sIL-SR may enhance the responsiveness of MG-63 cells to IL-6. Thus, IL-6 in collaboration with sIL-6R may modulate differentiation and proliferation of osteoblastic cells, presumably by activating two distinct signaling pathways of JAK-STAT and MAP kinase.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
R.Nishimura et al.: "Combination of Interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-Stat and MAP kinase pathways in MG-63 human osteoblastic osteosarcoma cells." J.Bone and Mineral Res.13・5. 777-785 (1998)
R. Nishimura 等人:“白细胞介素 6 和可溶性白细胞介素 6 受体的组合可诱导 MG-63 人成骨细胞骨肉瘤细胞中 JAK-Stat 和 MAP 激酶途径的分化和激活,J.Bone and Mineral Res.13・” 5.777-785(1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Moriyama et al.: "Transactions,8th International Congress on Cleft Palate and Related Craniofacial Anomalies" S.T.Lee,Stamford Press Pte Ltd,Singapore, 1066 (1997)
K.Moriyama 等人:“交易,第八届腭裂和相关颅面异常国际大会”S.T.Lee,Stamford Press Pte Ltd,新加坡,1066 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
N.funato et al.: "Evidence for apoptosis sigulating kinase(ASK)1 in the regenerating palatal epithelium upon acute injury." Lab.Invest.78・4. 477-483 (1998)
N.funato 等人:“急性损伤后腭上皮细胞凋亡调节激酶 (ASK)1 的证据。Lab.Invest.78·4 (1998)”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Yokozeki et al.: "Interferon-γ inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor-β1 in vitro." FEBS Letters. 442・1. 61-64 (1999)
M. Yokozeki 等人:“干扰素-γ 抑制体外转化生长因子-β1 诱导的大鼠腭成纤维细胞表型。” FEBS Letters 61-64 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
26
    Elucidation of etiology of facial asymmetry based on integrated genome-phenome analysis
    • 批准号:
      19H03857
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.07万
    • 财政年份:
      2019
    • 负责人:
      MORIYAMA Keiji
    • 依托单位:
    International comparative study on craniofacial morphology of Mongolian adolescents
    • 批准号:
      25305037
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.73万
    • 财政年份:
      2013
    • 负责人:
      MORIYAMA Keiji
    • 依托单位:
    Development of new technology for controlling suture remodeling using magnetized liposome with liposome
    • 批准号:
      23659963
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      MORIYAMA Keiji
    • 依托单位:
    Development of new therapeutic strategy for the craniosynostosis patients
    • 批准号:
      23390471
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2011
    • 负责人:
      MORIYAMA Keiji
    • 依托单位:
    国内基金
    海外基金
    早期滋养型肠内营养联合益生菌对重症卒中患者喂养耐受性及TNF-α/IL-6水平的影响研究
    七氟烷通过调控IL-6/FSP1轴抑制心肌铁死亡减轻心肌缺血再灌注损伤的机制研究
    • 批准号:
      JCZRLH202601296
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    盐酸小檗碱抑制NF-κB/IL-6/STAT3信号通路重塑免疫微环境并增敏肺癌免疫治疗的研究
    • 批准号:
      JCZRLH202600985
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    双歧杆菌与消退素RvD1协同调控IL-6/STAT3/Notch信号轴介导结肠癌EMT及免疫调节的机制研究
    • 批准号:
      JCZRLH202601410
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: